Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resource utilization implications of treatment were able to be assessed from appropriately reported clinical trial data.
Poole-Wilson PA, Kirwan BA, Vokó Z, de Brouwer S, Dunselman PH, van Dalen FJ, Lubsen J; ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators. Poole-Wilson PA, et al. Among authors: van dalen fj. J Clin Epidemiol. 2007 Jul;60(7):727-33. doi: 10.1016/j.jclinepi.2006.10.016. Epub 2007 Feb 23. J Clin Epidemiol. 2007. PMID: 17573989 Clinical Trial.
Quality management of a large randomized double-blind multi-centre trial: the ACTION experience.
Kirwan BA, Lubsen J, de Brouwer S, van Dalen FJ, Pocock SJ, Clayton T, Danchin N, Poole-Wilson PA; ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators. Kirwan BA, et al. Among authors: van dalen fj. Contemp Clin Trials. 2008 Mar;29(2):259-69. doi: 10.1016/j.cct.2007.10.001. Epub 2007 Oct 13. Contemp Clin Trials. 2008. PMID: 18029294
Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experience.
Kirwan BA, Lubsen J, de Brouwer S, Danchin N, Battler A, Bayes de Luna A, Dunselman PH, Glasser S, Koudstaal PJ, Sutton G, van Dalen FJ, Poole-Wilson PA; ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators. Kirwan BA, et al. Among authors: van dalen fj. Contemp Clin Trials. 2007 Nov;28(6):720-9. doi: 10.1016/j.cct.2007.04.001. Epub 2007 Apr 19. Contemp Clin Trials. 2007. PMID: 17509947 Clinical Trial.
Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.
Vermeer F, Simoons ML, de Zwaan C, van Es GA, Verheugt FW, van der Laarse A, van Hoogenhuyze DC, Azar AJ, van Dalen FJ, Lubsen J, et al. Vermeer F, et al. Among authors: van hoogenhuyze dc, van es ga, van der laarse a, van dalen fj. Br Heart J. 1988 May;59(5):527-34. doi: 10.1136/hrt.59.5.527. Br Heart J. 1988. PMID: 3132962 Free PMC article. Clinical Trial.
Antibody-peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins.
Petruzzella A, Bruand M, Santamaria-Martínez A, Katanayeva N, Reymond L, Wehrle S, Georgeon S, Inel D, van Dalen FJ, Viertl D, Lau K, Pojer F, Schottelius M, Zoete V, Verdoes M, Arber C, Correia BE, Oricchio E. Petruzzella A, et al. Among authors: van dalen fj. Nat Chem Biol. 2024 Sep;20(9):1188-1198. doi: 10.1038/s41589-024-01627-z. Epub 2024 May 29. Nat Chem Biol. 2024. PMID: 38811854
Effect of Antigen Valency on Autoreactive B-Cell Targeting.
van Weijsten MJ, Venrooij KR, Lelieveldt LPWM, Kissel T, van Buijtenen E, van Dalen FJ, Verdoes M, Toes REM, Bonger KM. van Weijsten MJ, et al. Among authors: van dalen fj. Mol Pharm. 2024 Feb 5;21(2):481-490. doi: 10.1021/acs.molpharmaceut.3c00527. Epub 2023 Oct 20. Mol Pharm. 2024. PMID: 37862070 Free PMC article.
18 results